EQTEC says awareness and growth activity is accelerating

Chief executive David Palumbo says its growth is built on market-leading technology and partnerships in key target markets.

EQTEC PLC - EQTEC says awareness and growth activity is accelerating

EQTEC PLC (LON:EQT) chief executive David Palumbo told investors that there’s growing awareness among potential customers of the company’s proposition.

Palumbo highlighted that the first half of 2020 has seen growth accelerate for EQTEC in terms of sales activity, contracting, and partner, pipeline and portfolio development.

“Our mission is to help the world reduce waste and generate green energy,” Palumbo said. “Our greatest contribution to that mission is producing the world's purest syngas for the widest variety of applications. 

He added: “Our continuing focus on growing EQTEC's pipeline has, in the first half of the year, created additional non-contracted tender opportunities worth a total potential of €341mln amongst which we sent full commercial offers worth a total of €205mln. 

READ: EQTEC eyes waste-to-energy project in Southport

“Although we see pipeline growth continuing in the second half of 2020 and beyond, we are also taking the opportunity to put in place greater discipline with financial close and with project execution.”

Palumbo noted that the accelerating growth is built upon market-leading waste gasification technology capabilities and industry partnerships across key target markets.

“In Europe, we have solid foundations from which we are expanding,” Palumbo said. “In the USA, we remain focused on further strengthening our relationship with Phoenix Energy in California.

“In Asia, we have received numerous enquiries, based on the strength of our technologies and the significant advantages our technologies have over alternatives in Asian markets including South Korea, Japan, Indonesia and Malaysia.”

"We expect strong pipeline growth to continue through H2 and our partner portfolio approach to continue bearing fruit.”

Amidst the COVID019 pandemic, however, the company notes that it has begun to see some delays in the closing of deals. It noted today that it expects delays with a small number of deals previously expected to close in the second half of 2020, now moving into the first half of 2021,

Palumbo highlighted that 2021 is seen by EQTEC as “potentially exponential” in terms of deal closures and revenue growth.

“Fuelled further by investment from EQTEC's own development capital in a majority of these opportunities, we believe we can both accelerate and secure financial closure of these and future deals.

“Through combining EQTEC technology, capital and strengthening partnerships around the world, we intend to scale our business and more effectively position ourselves to lead the growing gasification industry and to drive sustainable revenue and shareholder value."

In terms of its financial results, for the first half of 2020, the emerging green technology company reported €770,000 of revenue, albeit it noted that a further €958,837 was invoiced during the period in relation to the provision of technology and engineering services to North Fork Community Power – and this has yet to be realised in the statement of profit or loss.

It reported a €1.3mln operating loss for the six months and a net loss of €1.8mln.

The company ended June with €1.7mln of cash. Subsequently, an oversubscribed institutional equity fundraise brought in £10mln of new capital.

Quick facts: EQTEC PLC

Price: 0.545 GBX

Market: AIM
Market Cap: £37.43 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of EQTEC PLC named herein, including the promotion by the Company of EQTEC PLC in any Content on the Site, the Company receives from said issuer...


Market Report: FTSE jumps on AstraZeneca COVID-19 vaccine trial and easing...

FTSE 100 rallied in early trading on AstraZeneca’s COVID-19 vaccine trial and the easing of lockdown restrictions from December. London’s blue-chip index rose 20 to 6,371. AstraZeneca PLC (LON:AZN) announced that the coronavirus (COVID-19) vaccine it has developed with Oxford University was...

1 day, 16 hours ago

3 min read